Novus Biologicals has a range of new antibodies available. Products include: ABCA1; ABCA7; ACSL; Acetylcholinesterase; AGPAT6; Apo ER2; Aromatase; ASPM; ATPase; CD45; CD108; Ceramide Kinase; Dardarin; DJ-1; FATP; Fbp5B; Gli2; GLUT1; Gpihbo1; Gulp; HD lipoprotein-binding protein 1; Huntington; Jumonji; Kinesin; Klotho; LRP1; LRRK2; LXR; MRP-1; MSR; NCAM; NFkB; PC2; PKHD1; Phosphotyrosine; P6N1; RCD8; Slit1; Slit2; SREBP1; Tubulin-beta; UBE1C; UBP43; UCHL1; WFS1; WNK4; XCT; Zic2. Antibodies currently in development include: 67 kDa Laminin Receptor; GlyT2; Muscleblind-like 1; SOX2; Synaptojanin I; and TMP21.